Summit Announces Closing of Private Placement of $50 Million
Summit Therapeutics Inc.(“Summit” or the “Company”) Summit Announces Closing of Private Placement of $50 Million…
Month: November 2020
Theratechnologies Announces that Data on the Mechanism of Effect of Tesamorelin in NAFLD will be Presented at The Liver Meeting® 2020
MONTREAL, Nov. 06, 2020 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a…
Tauriga Sciences, Inc. Experiencing Greater Market Acceptance for its Cannabis (CBD & CBG) Infused Chewing Gum Product Line
NOV 6 PR Complete Tauri-Gum™ Product Line (6 Flavors) The Recent Improvements to the U.S….
Homology Medicines Announces Presentation of Positive Data from the Dose-Escalation Phase of the pheNIX Gene Therapy Trial for Adults with PKU
– Marked Reductions in Phe Observed at Two Doses – – Achieved Goal with Plans…
Virbac : Declaration of the number of shares and voting rights October 2020
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of…
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020
Bagsværd, Denmark, 6 November 2020 — This document discloses the data of the transaction(s) made…
Kannalife, Inc. Rebrands as Neuropathix, Inc. and Unveils New Ticker Symbol
DOYLESTOWN, Pa., Nov. 06, 2020 (GLOBE NEWSWIRE) — Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB:…
SCYNEXIS Reports Third Quarter 2020 Financial Results and Provides Company Update
In October, SCYNEXIS submitted a New Drug Application (NDA) for ibrexafungerp for the treatment of…
Equillium Announces Positive Interim Data of Itolizumab in the First-line Treatment of Acute Graft-Versus-Host Disease
100% overall response rate in dose cohort 3 and 80% overall response rate across all…
Aeterna Zentaris Reports Third Quarter 2020 Financial Results and Provides Business Update
– Pivotal Phase 3 safety and efficacy study AEZS-130-P02 (“Study P02”) expected to commence in…
Crinetics Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Reported positive topline results for the ACROBAT Edge and Evolve Phase 2 trials of oral…
Atreca to Present at Upcoming Virtual Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL),…
Atea Pharmaceuticals Expands Board of Directors with Appointment of Barbara Duncan
Experienced Financial Executive Brings Leadership and Public Company Expertise BOSTON, Nov. 06, 2020 (GLOBE NEWSWIRE)…
Bio-Path Holdings to Announce Third Quarter 2020 Financial Results on November 13, 2020
HOUSTON, Nov. 06, 2020 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company…
Shattuck Labs to Present Virtually at Cowen 4th Annual IO Next Summit
AUSTIN, TX and DURHAM, NC, Nov. 06, 2020 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
Vir Biotechnology Publishes New Research Characterizing Variation in the SARS-CoV-2 Spike Protein and Virulence of a Prevalent Immune Evasion Variant, N439K
– Manuscript highlights the importance of molecular surveillance of SARS-CoV-2 immune evasion and rational design…
Cocrystal Pharma to Present at the H.C. Wainwright 6th Annual Israel Conference
– Live video webcast with the Cocrystal management team, on Thursday, November 12th at 12:00…
Novo Nordisk to Acquire Emisphere Technologies for $1.35 Billion
ROSELAND, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) — Emisphere Technologies, Inc. (“Emisphere” or the “Company”)…
Invitation to Active Biotech’s virtual capital markets day
Active Biotech AB (publ) (ticker: ACTI) hereby invites analysts, investors and media to its virtual…
Ocugen Provides Business Update and Third Quarter 2020 Financial Results
First Gene Therapy Candidate OCU400 On Track to Enter the Clinic in 2021 MALVERN, Pa.,…